Section of Transplantation, Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
Am J Transplant. 2010 Nov;10(11):2512-9. doi: 10.1111/j.1600-6143.2010.03293.x.
We aimed to identify recipient, donor and transplant risk factors associated with graft failure and patient mortality following donation after cardiac death (DCD) liver transplantation. These estimates were derived from Scientific Registry of Transplant Recipients data from all US liver-only DCD recipients between September 1, 2001 and April 30, 2009 (n = 1567) and Cox regression techniques. Three years post-DCD liver transplant, 64.9% of recipients were alive with functioning grafts, 13.6% required retransplant and 21.6% died. Significant recipient factors predictive of graft failure included: age ≥ 55 years, male sex, African-American race, HCV positivity, metabolic liver disorder, transplant MELD ≥ 35, hospitalization at transplant and the need for life support at transplant (all, p ≤ 0.05). Donor characteristics included age ≥ 50 years and weight >100 kg (all, p ≤ 0.005). Each hour increase in cold ischemia time (CIT) was associated with 6% higher graft failure rate (HR 1.06, p < 0.001). Donor warm ischemia time ≥ 35 min significantly increased graft failure rates (HR 1.84, p = 0.002). Recipient predictors of mortality were age ≥ 55 years, hospitalization at transplant and retransplantation (all, p ≤ 0.006). Donor weight >100 kg and CIT also increased patient mortality (all, p ≤ 0.035). These findings are useful for transplant surgeons creating DCD liver acceptance protocols.
我们旨在确定与心脏死亡后(DCD)肝移植后移植物失败和患者死亡相关的受者、供者和移植风险因素。这些估计值来自 2001 年 9 月 1 日至 2009 年 4 月 30 日期间所有美国仅肝 DCD 受者的科学移植受者登记处(SRTR)数据(n=1567)和 Cox 回归技术。在 DCD 肝移植后 3 年,64.9%的受者存活且移植物功能正常,13.6%需要再次移植,21.6%死亡。显著预测移植物失败的受者因素包括:年龄≥55 岁、男性、非裔美国人、HCV 阳性、代谢性肝病、移植 MELD≥35、移植时住院和移植时需要生命支持(均,p≤0.05)。供者特征包括年龄≥50 岁和体重>100kg(均,p≤0.005)。冷缺血时间(CIT)每增加 1 小时,移植物失败率增加 6%(HR 1.06,p<0.001)。供体热缺血时间≥35min 显著增加移植物失败率(HR 1.84,p=0.002)。年龄≥55 岁、移植时住院和再次移植是患者死亡的受者预测因素(均,p≤0.006)。供者体重>100kg 和 CIT 也增加了患者死亡率(均,p≤0.035)。这些发现对制定 DCD 肝接受方案的移植外科医生有用。